These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 33114519)

  • 21. OCT biomarkers related to subthreshold micropulse laser treatment effect in central serous chorioretinopathy.
    Zheng F; He J; Su Z; Liu Y; Xu Y; Liu L; Ye P
    BMC Ophthalmol; 2022 Jun; 22(1):252. PubMed ID: 35668416
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An international collaborative evaluation of central serous chorioretinopathy: different therapeutic approaches and review of literature. The European Vitreoretinal Society central serous chorioretinopathy study.
    Romano MR; Parolini B; Allegrini D; Michalewska Z; Adelman R; Bonovas S; Bopp S;
    Acta Ophthalmol; 2020 Aug; 98(5):e549-e558. PubMed ID: 31808315
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Subthreshold laser compared to oral spironolactone for the treatment of chronic central serous chorioretinopathy: a retrospective study.
    Mercuri S; D'Alterio FM; Gallo B; Raslan W; Gupta A; Khairat N; Corazza P; Younis S
    Int Ophthalmol; 2024 Mar; 44(1):131. PubMed ID: 38478131
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Visual acuity correlates with multimodal imaging-based categories of central serous chorioretinopathy.
    Arora S; Maltsev DS; Sahoo NK; Parameshwarappa DC; Iovino C; Arora T; Kulikov AN; Tatti F; Venkatesh R; Reddy NG; Pulipaka RS; Singh SR; Peiretti E; Chhablani J
    Eye (Lond); 2022 Mar; 36(3):517-523. PubMed ID: 34645969
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oral Rifampin treatment for longstanding chronic central serous chorioretinopathy.
    Shulman S; Goldenberg D; Schwartz R; Habot-Wilner Z; Barak A; Ehrlich N; Loewenstein A; Goldstein M
    Graefes Arch Clin Exp Ophthalmol; 2016 Jan; 254(1):15-22. PubMed ID: 25794988
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 532 nm versus 810 nm subthreshold micropulse laser in treatment of non-resolving central serous chorioretinopathy: A randomized controlled trial.
    Ambiya V; Kumar A; Seth S; Kumar P; Oli A
    Med J Armed Forces India; 2024; 80(5):535-540. PubMed ID: 39309578
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term results and recurrence rates after spironolactone treatment in non-resolving central serous chorio-retinopathy (CSCR).
    Herold TR; Rist K; Priglinger SG; Ulbig MW; Wolf A
    Graefes Arch Clin Exp Ophthalmol; 2017 Feb; 255(2):221-229. PubMed ID: 27475933
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Subthreshold micropulse yellow laser (577 nm) in chronic central serous chorioretinopathy: safety profile and treatment outcome.
    Yadav NK; Jayadev C; Mohan A; Vijayan P; Battu R; Dabir S; Shetty B; Shetty R;
    Eye (Lond); 2015 Feb; 29(2):258-64; quiz 265. PubMed ID: 25613846
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Oral eplerenone for the management of chronic central serous chorioretinopathy.
    Singh RP; Sears JE; Bedi R; Schachat AP; Ehlers JP; Kaiser PK
    Int J Ophthalmol; 2015; 8(2):310-4. PubMed ID: 25938046
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Factors influencing the episode duration and the anatomical and functional outcome in cases of acute central serous chorioretinopathy.
    Parajuli A; Joshi P
    BMJ Open Ophthalmol; 2020; 5(1):e000540. PubMed ID: 33305002
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Oral Mineralocorticoid-Receptor Antagonists: Choroidal Parameters Changes Using OCT in Central Serous Chorioretinopathy.
    Faghihi H; Mohammadzadeh V; Nabavi A; Faghihi S; Kadivar S; Ghassemi F
    Ophthalmic Surg Lasers Imaging Retina; 2019 Nov; 50(11):726-733. PubMed ID: 31755972
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pattern electroretinography in patients with unilateral acute central serous chorioretinopathy.
    Doguizi S; Sekeroglu MA; Ozkoyuncu D; Yilmazbas P
    Clin Exp Optom; 2020 Sep; 103(5):656-662. PubMed ID: 31822040
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A Multicenter Study on the Long-term Outcomes of Half-dose Photodynamic Therapy in Chronic Central Serous Chorioretinopathy.
    Lai FH; Ng DS; Bakthavatsalam M; Chan VC; Young AL; Luk FO; Tsang CW; Brelén ME
    Am J Ophthalmol; 2016 Oct; 170():91-99. PubMed ID: 27519561
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Minoxidil induced central serous Chorioretinopathy treated with oral Eplerenone - a case report.
    Venkatesh R; Pereira A; Jain K; Yadav NK
    BMC Ophthalmol; 2020 Jun; 20(1):219. PubMed ID: 32503484
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Optical Coherence Tomography Parameters as Predictors of Treatment Response to Eplerenone in Central Serous Chorioretinopathy.
    Borrelli E; Zuccaro B; Zucchiatti I; Parravano M; Querques L; Costanzo E; Sacconi R; Prascina F; Scarinci F; Bandello F; Querques G
    J Clin Med; 2019 Aug; 8(9):. PubMed ID: 31443376
    [No Abstract]   [Full Text] [Related]  

  • 36. Continuous Laser Versus Micropulse Laser in the Treatment of Central Serous Chorioretinopathy: A Retrospective Study.
    Bica M; David A; Balta F; Iacob A
    Cureus; 2024 Feb; 16(2):e53799. PubMed ID: 38465179
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy of the subthreshold micropulse yellow wavelength laser photostimulation in the treatment of chronic central serous chorioretinopathy.
    Işık MU; Değirmenci MFK; Sağlık A
    Int J Ophthalmol; 2020; 13(9):1404-1410. PubMed ID: 32953579
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of two protocols of subthreshold micropulse yellow laser treatment for non-resolving central serous chorioretinopathy.
    Beniwal A; Shaikh N; Chawla R; Azad SV; Kumar V; Vohra R
    Indian J Ophthalmol; 2022 Sep; 70(9):3341-3345. PubMed ID: 36018117
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical characteristics of chronic central serous chorioretinopathy patients with insufficient response to reduced-settings photodynamic therapy.
    van Rijssen TJ; van Dijk EHC; Dijkman G; Boon CJF
    Graefes Arch Clin Exp Ophthalmol; 2018 Aug; 256(8):1395-1402. PubMed ID: 29732468
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Combined Topical Anti-inflammatory and Oral Acetazolamide in the Treatment of Central Serous Chorioretinopathy.
    Wuarin R; Kakkassery V; Consigli A; Roquelaure D; Papanastasiou A; Schutz JS; Thumann G; Chronopoulos A
    Optom Vis Sci; 2019 Jul; 96(7):500-506. PubMed ID: 31274738
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.